CIK 0001707502
- Non-accelerated filer
- Smaller reporting company
Solid Biosciences Inc.
Sign in to watch- Ticker
- SLDB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900943402
- Phone
- +1 617-337-4680
- Business address
- 500 RUTHERFORD AVENUE, 3RD FLOOR, CHARLESTOWN, MA, 02129
- Former names
- Solid Biosciences, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $24,582
- in 1 filing, $25K under 10b5-1 plans
Net −$24,582. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-12 | Ganot Ilan CEO & President | Exercise or conversion · Restricted Stock Unit | −800 | 2,430 | ||
| 2020-02-10 | Ganot Ilan CEO & President | Grant or award | +2,430 | 2,430 | ||
| 2020-01-27 | Ganot Ilan CEO & President | Grant or award · Employee Stock Option (Right to Buy) | +4,320 | 4,320 | ||
| 2020-01-27 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Grant or award · Employee Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2020-01-27 | Ziolkowski Jennifer Lynn CFO, Treasurer & Asst. Secy | Grant or award · Restricted Stock Unit | +23,000 | 23,000 | ||
| 2020-01-27 | Schneider Joel Solomon Zev Chief Technology Officer | Grant or award · Employee Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2020-01-27 | Schneider Joel Solomon Zev Chief Technology Officer | Grant or award · Restricted Stock Unit | +23,000 | 23,000 | ||
| 2020-01-27 | Morris Carl Ashley Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +47,000 | 47,000 | ||
| 2020-01-27 | Morris Carl Ashley Chief Scientific Officer | Grant or award · Restricted Stock Unit | +23,000 | 23,000 | ||
| 2020-01-27 | HERSCHA LYNETTE Chief Legal Officer | Grant or award · Employee Stock Option (Right to Buy) | +65,000 | 65,000 | ||
| 2020-01-27 | HERSCHA LYNETTE Chief Legal Officer | Grant or award · Restricted Stock Unit | +32,000 | 32,000 | ||
| 2020-01-27 | Ganot Ilan CEO & President | Grant or award · Employee Stock Option (Right to Buy) | +142,000 | 142,000 | ||
| 2020-01-27 | Ganot Ilan CEO & President | Grant or award · Restricted Stock Unit | +71,000 | 71,000 | ||
| 2020-01-02 | Zarur Juan Andrey Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-08-12 | Ganot Ilan CEO & President | Grant or award · Restricted Stock Units | +1,600 | 1,600 | ||
| 2019-07-30 | Koppel Adam Director | Grant or award | +1,881,720 | $4.65 | $8.7M | 3,871,164 |
| 2019-07-25 | Shah Rajeev M. Director | Grant or award | +1,881,720 | $4.65 | $8.7M | 4,571,164 |
| 2019-07-25 | Nagendran Sukumar Director | Grant or award | +32,258 | $4.65 | $150K | 34,258 |
| 2019-07-25 | Morris Carl Ashley Chief Scientific Officer | Grant or award | +21,505 | $4.65 | $100K | 133,050 |
| 2019-07-25 | Ganot Ilan CEO & President | Grant or award | +21,505 | $4.65 | $100K | 1,123,631 |
Page 26 of 31 · 604 trades